A Cure in Sight and the Ocular Melanoma Foundation Collaborate to Host Webinar on PERIO-01 Clinical Trial for Uveal Melanoma with Liver Metastases

Apr 20, 2022 | Oncology

A Cure in Sight, in collaboration with the Ocular Melanoma Foundation, hosted an educational webinar on the Pressure-Enabled Regional Immuno-Oncology-01 (PERIO-01) clinical trial for uveal melanoma with liver metastases. This webinar featured insights from Drs. Richard D. Carvajal, Steven C. Katz and Joshua L. Weintraub on emerging strategies in the treatment of metastatic uveal melanoma, barriers to immunotherapy success for uveal melanoma liver metastases, and the ongoing PERIO-01 clinical trial for adults with uveal melanoma with liver metastases. Following the presentation, these physicians were joined by Ashley Moody of TriSalus Life Sciences to discuss information on trial involvement for patients and answer audience questions. More information on the PERIO-01 clinical trial can be found at www.periotrial.com.